Individual decision · SEC · 7 Oct 2011
The Division of Corporation Finance will not recommend enforcement action against Textron, Inc. for using a specific pricing mechanism in its issuer cash tender offer for 4.50% Convertible Senior Notes due 2013, involving 75% of the Parity Value plus a fixed cash amount. This relief applies to the application of Rules 13e-4(d)(1), 13e-4(f)(1)(ii), and 14e-1(b) under the Securities Exchange Act of 1934, provided the Company adheres to disclosed minimum and maximum purchase prices and transparency requirements. The Company must publish daily indicative prices, announce the final price by 4:30 p.m. on the Expiration Date, and extend the offer if the price equals the maximum. This position is strictly limited to the described pricing mechanism and does not constitute a legal conclusion on other applicable laws.
Securities Exchange Act of 1934 Rule 13e-4 — Issuer Tender Offers
Response of the Office of Mergers and Acquisitions Division of Corporation Finance
Re:
Textron, Inc. Incoming letter dated October 7, 2011
Todd W. Eckland, Esq. Pillsbury Winthrop Shaw Pittman LLP 1540 Broadway New York, NY 10036
RE: VWAP Pricing in Issuer Cash Tender Offer by Textron Inc.
Dear Mr. Eckland:
We are responding to your letter dated October 7, 2011 addressed to Michele M. Anderson and Daniel F. Duchovny, as supplemented by telephone conversations with the staff, with regard to your request for no-action relief. To avoid having to recite or summarize the facts set forth in your letter, our response is attached to the enclosed copy of your letter. Unless otherwise noted, capitalized terms in this letter have the same meaning as in your letter.
On the basis of your representations and facts presented in your letter, the staff of the Division of Corporation Finance will not recommend that the Securities and Exchange Commission take enforcement action under Rules 13e-4(d)(1), 13e-4(f)(1)(ii) and 14e-1(b) under the 1934 Act if the Company conducts the Offer by using the Pricing Mechanism as described in your letter. In issuing this no-action position, we considered the following facts, among others:
the Offer to Purchase discloses the Pricing Mechanism for determining the final purchase price per Subject Security equal to the sum of 75% of the Parity Value plus a fixed amount of cash (together with any accrued and unpaid interest);
the Offer to Purchase includes an illustrative table showing calculations of the purchase price;
the Offer to Purchase discloses fixed minimum and maximum purchase prices that will be paid by the Company for each Subject Security tendered and purchased;
the Pricing Mechanism and the minimum and maximum prices will remain fixed throughout the duration of the Offer; and, if there is a change in the Pricing Mechanism or the minimum or maximum price, the Offer will remain open for at least 10 business days;
the Offer will be automatically extended until midnight, New York City time, on the second trading day following the originally scheduled Expiration Date if the purchase price will equal the Maximum Purchase Price;
the Common Stock used as the reference security in the Pricing Mechanism is listed on the New York Stock Exchange;
the Company’s belief that the value of the Subject Securities is directly correlated to the trading price of the Common Stock;
the Company will publish the daily indicative calculated purchase prices per Subject Security on a webpage maintained for the Offer and has provided a toll-free number that holders of the Subject Securities can use to obtain pricing related information;
the Company will publish the final purchase price on the Offer webpage and in a press release no later than 4:30 p.m., New York City time, on the Expiration Date of the Offer, and electronically file that information on an amended Schedule TO;
the Company has made available forms of VOI and notice of withdrawal in its printed offering materials and on the Offer webpage, will permit tenders and withdrawals to be made until midnight on the Expiration Date, and has disclosed the procedures for making tenders and withdrawals in the offering materials;
the Offer to Purchase includes disclosure informing beneficial holders of the Subject Securities that they must make arrangements with their brokers or similar institutions for such brokers or similar institutions to fax a VOI or notice of withdrawal (as applicable) to the Depositary on such beneficial holders’ behalf prior to midnight, New York City time, on the Expiration Date; and
the Offer to Purchase discloses that the Company is seeking to buy any and all of the Subject Securities.
The foregoing no-action position is based solely on your representations and the facts presented in your letter dated October 7, 2011 as supplemented by telephone conversations with the staff. Any different facts or circumstances may require a different conclusion. This relief is strictly limited to the application of Rules 13e-4(d)(1), 13e-4(f)(1)(ii) and 14e-1(b) to the Company’s use of the Pricing Mechanism. This response expresses the Division’s position on enforcement action only and does not express any legal conclusion on the question presented. The Company should discontinue the Offer pending further consultations with the staff if any of the facts or representations set forth in your letter change.
We also direct your attention to the anti-fraud and anti-manipulation provisions of the federal securities laws, including Sections 9(a), 10(b) and 14(e) of the 1934 Act and Rules 10b-5, 13e-4(j) and 14e-3 thereunder. Responsibility for compliance with these and any other applicable provisions of the federal securities laws rests with the participants in the Offer. The Division of Corporation Finance expresses no view with respect to any other questions that the Offer may raise, including any questions relating to the adequacy of the disclosure regarding, and the applicability of any other federal or state laws to, the Pricing Mechanism or the Offer.
Sincerely,
Michele M. Anderson Chief Office of Mergers and Acquisitions Division of Corporation Finance
Incoming Letter:
The Incoming Letter is in Acrobat format.
~lllsDur~ Pillsbury Winthrop Shaw Pittman LLP
1540 Broadway I New York, NY 10036-4039 I tel 212.858.1000 I fax 212.858.1500 Todd W. Eckland tel 212.858.1440 todd.eckland@Pillsburylaw.com VIAE-MAIL Office ofMergers and Acquisitions Mail Stop 3628 100 F Street, N.E. Washington, D.C. 20549-3628 Attn: Michele M. Anderson, Chief Daniel F. Duchovny, Special Counsel Re: VWAP Pricing in Issuer Cash Tender Offer by Textron Inc. Ladies and Gentlemen:
We are writing on behalf ofour client Textron Inc., a Delaware corporation (the "Company"), in connection with the Company's offer to purchase for cash any and all ofthe Company's outstanding 4.50% Convertible Senior Notes due 2013 (the "Subject Securities") upon the terms and subject to the conditions set forth in the Company's Offer to Purchase, dated September 14, 2011 (the "Offer to Purchase"), and the related Letter ofTransmittal (together with the Offer to Purchase, the "Offer"), at a purchase price per Subject Security! determined in accordance with the Pricing Mechanism (as defined below). The Subject Securities are convertible into shares ofthe Company's common stock (the "Common Stock"), which is listed for trading on the New York Stock Exchange. Accordingly, the Offer is subject to Rule 13e-4 under the Securities Exchange Act of 1934 (the "1934 Act") in addition to Regulation 14E under the 1934 Act, and on ! As used in this letter, any reference to a price or value "per Subject Security" or "for each Subject Security" means a price or value per $1,000 principal amount ofSubject Securities. www.pillsburylaw.com 601553669-v6-Draft No Action Letter.DOC
Office ofMergers and Acquisitions
October 7,2011
September 14, 2011 the Company filed with the Securities and Exchange Commission (the "SEC") a Tender Offer Statement on Schedule TO in connection with the Offer, which Tender Offer Statement on Schedule TO was subsequently amended on September 15 and September 21,2011 (as so amended, the "Schedule TO"). We are writing to request, on behalf ofthe Company, that the Staff (the "Staff) ofthe SEC confirm that it will not recommend that the SEC take enforcement action against the Company pursuant to Rules 13e-4(d)(1), 13e-4(f)(1)(ii) and 14e-1(b) under the 1934 Act with the respect to the Company's use ofthe Pricing Mechanism to determine the purchase price to be paid per Subject Security pursuant to the Offer.
I. The Offer
The Company is offering to purchase any and all ofthe outstanding Subject Securities pursuant to the Offer, which is currently scheduled to expire at midnight, New York City time, on October 12, 2011 (the "Expiration Date"), which is 20 business days after the September 14, 2011 commencement date ofthe Offer (the "Commencement Date"). There is no minimum tender condition to the Offer. All ofthe Subject Securities are held in book-entry form through the facilities of The Depository Trust Company ("DTC"), and all ofthe Subject Securities are currently represented by one or more global certificates held for the account ofDTC. The Company has advised us that it believes that substantially all ofthe holders ofthe Subject Securities are institutional investors, with over 75% ofthe Subject Securities held by a small number of convertible arbitrageurs and similar investors that typically hedge their convertible note holdings by shorting the underlying common stock and substantially all ofthe balance held by other institutional investors. Participation in the Offer by holders ofSubject Securities is entirely voluntary. None ofthe Company, its Board ofDirectors or any dealer manager for the Offer is making any recommendation to holders ofSubject Securities as to whether or not to participate in the Offer. Subject Securities that are not purchased in the Offer will remain outstanding on their current terms and conditions. Subject Securities purchased by the Company in the Offer will be cancelled and retired:
Because the trading price ofthe Common Stock on the New York Stock Exchange is currently significantly in excess ofthe conversion price ofthe Subject Securities (i.e., the Subject Securities are "in the money"), the Company believes that the value ofthe www.pillsburylaw.com 601553669-v6-Draft No Action Letter.DOC
Office ofMergers and Acquisitions
Subject Securities is directly correlated to the trading price ofthe Common Stock.2 Accordingly, the price which the Company is offering to pay for each Subject Security tendered and purchased in the Offer will be determined by reference to the Average VWAP for the Common Stock. For purposes ofthe Offer, the "Average VWAP" is the simple arithmetic average ofthe daily VWAP over an averaging period of20 consecutive trading days ending on the Expiration Date (the "VWAP Averaging Period"), and the daily VW AP of any trading day is the per share volumeweighted average price ofthe Common Stock in trades that take place from the scheduled open oftrading (9:30 a.m., New York City time) to the scheduled close of trading (4:00 p.m., New York City time) on that trading day, as displayed under the heading "Bloomberg VWAP" on Bloomberg page TXT.N <Equity> AQR. The Offer to Purchase provides that the purchase price per Subject Security will be equal to the sum of(A) the Average VWAP multiplied by 57.1429, which is 75% of the number ofshares ofCommon Stock into which such Subject Security is currently convertible in accordance with its terms,plus (B) a fixed cash amount of$504.50 (the "Pricing Mechanism"). In addition, holders of Subject Securities purchased in the Offer will receive accrued and unpaid interest on their Subject Securities to, but excluding, the settlement date ofthe Offer. Furthermore, the Offer to Purchase discloses a fixed minimum purchase price of$1,075.93 and a fixed maximum purchase price of$I,790.22 (the "Maximum Purchase Price") that will be paid by the Company for each Subject Security tendered and purchased pursuant to the Offer.3 The Offer further provides that ifthe purchase price will equal the Maximum Purchase Price, then the Offer will be automatically extended until midnight, New York City time, on the second trading day following the originally scheduled Expiration Date to enable holders to determine whether or not to tender their Subject Securities or to withdraw any previously tendered Subject Securities. 2 The conversion rate for the Subject Securities is 76.1905 shares for each $1,000 principal amount of Subject Securities. This corresponds to a conversion price of $13.125 per share of Common Stock. On October 6, 20 11, the closing price per share of the Common Stock on the New York Stock Exchange was $18.47. As described in greater detail in the "Discussion" section below, the Company has observed a direct correlation between the value of the Subject Securities and the trading price of the Common Stock. 3 For purposes of this letter, the Company acknowledges that a change in the Pricing Mechanism or a change in the minimum or maximum purchase price would constitute a change in the consideration offered for the Subject Securities within the meaning of Rules 13e-4(t)(1)(ii) and 14e-l{b) and would require the Offer to remain open for at least 10 business days from the date that notice of such change is first published or
sent or given to holders of the Subject Securities. www.pilisburylaw.com 601553669-v6-Draft No Action Letter,DOC
Office ofMergers and Acquisitions
Division of Corporation Finance
Accordingly, investors will generally benefit from increases in the value of the Common Stock during the VWAP Averaging Period. The Offer to Purchase includes on pages 3 and 17 tables showing illustrative calculations ofthe purchase price based on a range ofhypothetical Average VWAP values for the Common Stock. The Offer to Purchase includes a link to a webpage (http://www.gbscusa.comlTextron) that is providing updated indicative purchase prices per Subject Security during the term ofthe Offer. In particular:
Office ofMergers and Acquisitions price per Subject Security that reflect the simple arithmetic average ofthe daily VWAP on the preceding trading days of the VWAP Averaging Period and the actual intra-day volumeweighted average price during the elapsed portion ofsuch subsequent trading day, weighting the daily VWAP for each preceding trading day in the period the same as such actual intra-day volume-weighted average price. For example, based on the VWAP Averaging Period of 20 trading days, at any time during the 20th trading day ofthe VWAP Averaging Period, the webpage will show the indicative Average VWAP equal to (a) the combined daily VWAP for the preceding 19 trading days plus the actual intra-day volume-weighted average price during the elapsed portion ofthe 20th trading day divided by (b) 20, as well as the resulting indicative purchase price per Subject Security. o Each time the webpage is updated, it will also show a reasonably current trading price (and, before the VWAP Averaging Period started, it showed the closing trading price) for the Common Stock on the New York Stock Exchange. 5 The Offer to Purchase also discloses a toll-free telephone number that holders ofthe Subject Securities can call to contact the information agent for the Offer to obtain the same information that is posted on the webpage. The Company will announce the fmal purchase price per Subject Security by press release and on the webpage no later than 4:30 p.m., New York City time, on the Expiration Date, and will amend the Schedule TO to disclose the final purchase price per Subject Security and attach the press release as an exhibit. 5 We do not believe it would be useful for the webpage to include regularly updated trading prices for the Subject Securities because (a) the Subject Securities are not listed, there is no other established public market for them, the trading market for them is not active, prices reported for them by Bloomberg and other pricing services are sporadic and as a result we question whether updated values for them would be meaningful and (b) based on the limited pricing data available for the Subject Securities, the Company believes that the value of the Subject Securities is directly correlated to the trading prices of the shares of Common Stock into which they are convertible. We also note that there is no requirement for an offeror in a cash tender offer for debt securities to provide updated trading prices for the subject debt. wvwv.pillsburylaw.com 601553669-v6-Draft No Action Letter,DOC
Office ofMergers and Acquisitions
October 7,2011
Holders ofthe Subject Securities will have withdrawal rights until the Offer expires. Because the Offer will expire at midnight, New York City time, on the last day ofthe VWAP Averaging Period approximately 7.5 hours after the Company announces the final purchase price per SUbject Security - holders will have an opportunity for last-minute tenders and withdrawals (except ifthe final purchase price equals the Maximum Purchase Price, in which case the Offer will be automatically extended as described above). In this regard, we note the following:
Office ofMergers and Acquisitions
October 7,2011 for tendering Subject Securities by means of a VOl is disclosed on pages 5 and 21 ofthe Offer to Purchase.
II. Discussion
We have been advised by the Company that,because the Subject Securities by their terms are convertible into shares ofCommon Stock, a cash payment or a combination ofshares ofCommon Stock and a cash payment, with the amounts of any such cash payments based on the value ofthe Common Stock (and the conversion price per share is currently significantly less than the current trading price ofthe COlnmon Stock), the Company believes that there is a direct correlation between the price at which holders of Subject Securities would be willing to tender their respective Subject Securities and the trading price ofthe Common Stock at the time ofsuch tender. Although the Subject Securities are not publicly traded, the Company has observed, based on the limited pricing data available, a direct correlation between the value ofthe Subject Securities and the trading price ofthe Common Stock.7 In light ofthis correlation, the Company has determined the purchase price in accordance with a formula that offers holders ofthe Subject Securities a cash purchase price per Subject Security based on the trading price ofthe Common Stock (which will be equal to 75% of the value ofthe underlying shares ofCommon Stock per Subject Security) plus a fixed cash payment (subject to the minimum and maximum purchase prices), as described in more detail above.s 7 To assess the correlation between the values ofthe Subject Securities and the trading prices of the Conunon Stock, the Company compared such amounts for the past two years. The Company observed that the square of the price correlation coefficient ("R-Squared") of the Subject Securities with respect to the Conunon Stock was 99% (with 100% being perfectly correlated). We have supplementally provided to the Staff graphs that illustrate this correlation. This correlation indicates that the value of the Subject Securities is highly sensitive to movements in the trading price of the Conunon Stock such that an increase (or decrease) in the trading price of the Conunon Stock results in an almost dollar-for-dollar increase ( or decrease) in the value of the Subject Securities. Because ofthis price sensitivity, the Company believes that the use of a pricing formula is the optimal means of presenting the amount of the Offer consideration. S The Company, after extensive consultation with the dealer managers for the Offer, developed the pricing formula to provide holders with a cash premium over the value ofthe Subject Securities, which, as discussed above, is correlated to the value ofthe number ofshares of Conunon Stock into which such Subject Security is currently convertible in accordance with its terms (the "Parity Value"). Because the Company desires to purchase Subject Securities even ifthey are "out ofthe money" with a conversion price in excess ofthe Average VWAP should the trading prices ofthe Conunon Stock decrease significantly below current trading levels, the Company determined to base (... continued) www.pillsburylaw.com
601553669-v6-Draft No Action Letter.DOC
Office ofMergers and Acquisitions
The Pricing Mechanism uses the VWAP Averaging Period, which ends on the Expiration Date rather than two business days prior to the Expiration Date (so-called "Day 18" pricing), because, ifDay 18 pricing were used, increases in the trading price ofthe Common Stock during the last two business days ofthe Offer could cause the purchase price per Subject Security offered pursuant to the Offer to be less than the value ofthe Subject Securities on the Expiration Date, requiring the Company to increase the purchase price per Subject Security in the Offer (subject to the Maximum Purchase Price) to induce holders of the Subject Securities to tender (or not withdraw) their Subject Securities. Similarly, a decrease in the trading price ofthe Common Stock during the last two business days ofthe Offer could cause the purchase price per SUbject Security offered pursuant to the Offer to be greater than the value of Subject Securities in the Offer, requiring the Company to reduce the purchase price per Subject Security in the Offer (subject to the minimum purchase price) to avoid "over paying" for the Subject Securities to the detriment of the Company and its stakeholders who are not holders ofthe Subject Securities.9 With Day 18 pricing, increases or decreases in the purchase price per Subject Security to offset potential fluctuations in the trading price ofthe Common Stock during the last two business days ofthe Offer could be necessitated on multiple occasions, with each such increase or decrease requiring an extension ofthe Offer pursuant to Rules 13e-4(f)(I)(ii) and 14e-l(b) and, in theory, resulting in the Offer being extended in perpetuity. The potential for multiple extensions ofthe Offer could create a significant amount of uncertainty as to when, or if, the Offer would ever be completed. (... continued) the pricing fonnula on 75% ofthe Parity Value plus a significant fixed cash payment to provide holders with a relatively constant cash premium over the value oftheir Subject Securities in order to induce holders to tender their Subject Securities and to avoid "over paying" for SUbject Securities that are "out ofthe money" to the detriment ofthe Company and its stakeholders who are not holders ofthe Subject Securities. 9 While the minimum purchase price per Subject Security contemplated by the Offer presents some risk that the Company will "over pay" for the Subject Securities in the Offer, the Company believes that this risk is outweighed by the benefit of the certainty afforded by the minimum purchase price to holders of the Subject Securities and the Company in the event that the trading price of the Common Stock decreases significantly during the Offer. The Company has established the Maximum Purchase Price to cap the maximum amount of cash required to purchase all ofthe Subject Securities tendered in the Offer. Because the Maximum Purchase Price presents a risk that the Company will pay less for the Subject Securities than their value, ifthe
purchase price will equal the Maximum Purchase Price, the Offer will be automatically extended for two trading days as described above. www.pillsburylaw.com 601553669-v6-Draft No Action Letter.DOC
Office ofMergers and Acquisitions
As compared to a pricing mechanism that uses Day 18 pricing, the Pricing Mechanism, with the VWAP Averaging Period ending on the Expiration Date, fosters greater certainty for the Company and holders ofthe Subject Securities by establishing a final purchase price that is more closely correlated to the value ofthe Subject Securities on the Expiration Date and thereby reducing the likelihood of a last-minute pricing amendment and consequent extension ofthe Offer, which extension would necessarily delay payment ofthe purchase price to tendering holders ofSubject Securities. lO The Pricing Mechanism establishes the purchase price per Subject Security in a simple, easy-to-understand and transparent fashion. Holders ofthe Subject Securities at all times from the Commencement Date will know the exact mechanism for determining the final purchase price per Subject Security, as well as the fixed cash payment and the minimum and maximum purchase prices that the Company will pay for the Subject Securities. The holders ofthe Subject Securities have free and ready access to updated indicative pricing information, and they will have time to tender or withdraw their Subject Securities after the final purchase price per Subject Security is announced, enabling them to make informed decisions about whether or not to tender. In addition, ifthe purchase price will be the Maximum Purchase Price, the Offer will be automatically extended until midnight, New York City time, on the second trading day following the originally scheduled Expiration Date to afford holders of Subject Securities with two additional trading days to determine whether or not to tender or to withdraw any previously tendered Subject Securities. We believe that holders ofthe Subject Securities expect to receive a specified cash payment in addition to 75% ofthe Parity Value of each Subject Security tendered. Imposing an arbitrary multi-day time delay between the time that the final purchase price per Subject Security is determined and expiration ofthe Offer will interfere with that expectation (increasing the chance that the cash value delivered at expiration by the Company will differ substantially from the amount expected by holders ofthe Subject Securities) and is not necessary for the protection ofinvestors. 10 It is possible that the closing price of the Common Stock on the Expiration Date may differ significantly from the Average VW AP used to determine the final purchase price per Subject Security in the Offer, but we believe that the use of a VW AP Averaging Period that ends on the Expiration Date provides a reasonable balance between the objectives ofproviding the most current pricing practicable and reducing price distortions that could occur if prices were established at a single point in time. www.pillsburyJaw.com 601553669-v6-Draft No Action Letter.DOC
Office ofMergers and Acquisitions
We also note that the Company believes that substantially all ofthe holders ofSubject Securities are institutional investors, with, as mentioned above, over 75% held by convertible arbitrageurs and similar investors that typically hedge their convertible note holdings. Such institutional investors have prior experience with tender offers and exchange offers in which the price was determined in a manner similar to the Pricing Mechanism. Therefore, the Company believes that holders ofthe Subject Securities are able to analyze the Pricing Mechanism and make informed decisions whether or not to tender Subject Securities (or to withdraw previously tendered Subject Securities) in the time periods described in the Offer to Purchase, especially given the continuous flow ofindicative pricing information being provided by the Company through the website and telephone numbers established for this purpose. For these reasons, we believe that the Pricing Mechanism complies with the applicable rules, is not coercive or unfair and should be permitted. Below we set forth additional reasons why we believe the Pricing Mechanism complies with applicable SEC rules and should be permitted. Rules 13e-4(j)(1 )Ui) and 14e-1 (k) under 1934 Act Rules 13e-4(f)(1)(ii) and 14e-I(b) under the 1934 Act, in relevant part, require a tender offer to remain open for at least 10 business days after notice of an increase or decrease in the consideration offered is first published, sent or given to security holders. In our view, the consideration offered for each Subject Security in the Offer is a fixed cash amount in addition to 75% ofthe Parity Value ofthe Subject Security (subject to the minimum and maximum purchase prices), payable in cash, with 75% ofthe Parity Value calculated as a function of the Average VWAP over the VWAP Averaging Period. The Company announced that consideration at the commencement ofthe Offer, and we do not believe the arithmetic calculation ofthe final purchase price per Subject Security on the Expiration Date will be a change in "the consideration offered" within the meaning ofRules 13e-4(f)(1)(ii) and 14e-1(b) under the 1934 Act. Rule 13e-4 (d)(1 ) under the 1934 Act Rule 13e-4(d)(1) under the 1934 Act requires that the issuer in an issuer tender offer disclose the information required by Schedule TO, which, in turn, requires by Item 4 thereof, that the issuer disclose the amount of consideration offered for the securities subject to the tender offer. Because the Pricing Mechanism, instead of a fixed price, is being used in an effort to comply with Item 4 of Schedule TO, there is some uncertainty as to whether disclosure ofthe Pricing Mechanism satisfies this Item of the Schedule. For the same reasons we discuss above with respect to Rules 13e4(f)(I)(ii) and 14e-l(b), we believe that the Offer to Purchase, which describes the www.pillsburylaw.com 601553669-v6-Draft No Action Letter.DOC
Office ofMergers and Acquisitions precise manner in which the final purchase price per Subject Security will be calculated, includes a full description ofthe consideration offered and that the absence ofthe final purchase price per Subject Security in the Offer to Purchase will not violate Rule 13e-4( d)(l) under the 1934 Act. In this regard, we acknowledge that the Company is not seeking an exemption from the disclosure requirements of
Schedule TO. Rather, the Company believes that, ifthe Staff grants the requested noaction relief under Rule 13e-4(d)(I), the disclosure in the Offer to Purchase ofthe
Pricing Mechanism would be deemed not to be inconsistent with the disclosure requirements of Schedule TO.
Section 14(e) 0{1934 Act
Section 14( e) ofthe 1934 Act prohibits any person from omitting to state any material
fact necessary in order to make the statements made in connection with a tender offer, in the light ofthe circumstances under which they were made, not misleading. For the same reasons we discuss above with respect to Rules 13e-4(d)(l), 13e-4(f)(l)(ii) and 14e-l (b), we believe that the Offer to Purchase, which describes the precise manner in which the final purchase price per Subject Security will be calculated, includes a full description ofthe consideration offered and that the absence ofthe final purchase price per Subject Security does not constitute an omission of a material fact that would violate Section 14(e) ofthe 1934 Act. Extension o{Prior No-Action Letters The Staff has long permitted formula pricing in the context of exchange offers. I I In a letter for TXU Corp. (September 13, 2004), the Staff extended this rationale to issuer cash tender offers and granted no-action relief relating to Rules 13e-4( d)(l), 13e4(f)(I)(ii) and 14e-I(b) under the 1934 Act for an issuer tender offer in which TXU used a Day 18 pricing formula to determine the purchase price it offered for its outstanding equity units and convertible notes (with the final purchase prices per security being determined two business days prior to the expiration of TXU'stender offers). In letters for McDonald's Corporation (September 27,2006), Weyerhaeuser Company (February 23,2007), Halliburton Company (March 23,2007) and Kraft Foods Inc. (July 1,2008) (collectively, the "Day 20 Split-Off Letters"), the Staff 11 See, e.g., the Staffs letters for Lazard Freres & Co. (August 11,1995), AB Volvo (May 16, 1997) and Epicor Software Corporation (May 13, 2004). www.pillsburylaw.com 601553669-v6-Draft No Action Letter.DOC
Office ofMergers and Acquisitions
Division of Corporation Finance
October 7,2011 granted no-action relief relating to Rules 13e-4(d)(I), 13e-4(f)(l)(ii) and 14e-l(b) under the 1934 Act pennitting companies involved in split-off exchange offers to price the common shares being offered and the common shares being acquired based on volume-weighted average prices over a two- or three-trading day averaging period ending on the last day of the applicable exchange offer, so-called "Day 20" pricing."12 In a letter for Citizens Republic Bancorp, Inc. (August 21,2009), the Staff granted no-action relief relating to Rule 14e-l (b) under the 1934 Act pennitting the offerorto issue a fixed dollar value ofits common stock in exchange for its outstanding nonconvertible subordinated notes and trust preferred securities, with the final number of shares of common stock to be issued being detennined on the expiration date ofthe exchange offer. 13 Subsequent to the Citizens Republic letter, in a letter for Thenno Fisher Scientific Inc. (November 13, 2009), the Staff granted no-action relief relating to Rules 13e-4( d)(1), 13e-4(f)(l)(ii) and 14e-1 (b) under the 1934 Act with respect to an offer with a Day 20 pricing mechanism substantially similar to the Pricing Mechanism and with structural protections, such as daily publishing of indicative calculated purchase prices on a 12 We note that the pricing mechanisms in the exchange offers described by the Day 20 Split-Off Letters generally limited the maximum number of shares that would be issued by the offerors, which could result in tendering holders receiving a value for their tendered securities less than the disclosed value. As a result, the offerors in the Day 20 Split-Off Letters undertook to extend their respective offers by two trading days in the event that the maximum share limitations were in effect to give holders additional time to determine whether or not to tender their securities. As with the exchange offers described in the Day Split-Off 20 Letters, the Offer provides that if the purchase price equals the Maximum Purchase Price, the Offer will be automatically extended by two trading days to give holders additional time to determine whether or not to tender their Subject Securities or to withdraw any previously tendered Subject Securities. In addition, the minimum purchase price contemplated by the Offer protects tendering holders by ensuring that tendering holders will receive at least the minimum cash amount in exchange for their tendered Subject Securities, notwithstanding a decline in the trading price ofthe Common Stock (and a corresponding decline in the value of the Subject Securities) during the Offer. Because the minimum purchase price contemplated by the Offer does not present the same risk as the Maximum Purchase Price or the maximum share limitations contemplated by the exchange offers described in the Day 20 Split-Off Letters, we do not believe it is necessary to undertake to extend the Offer in the event that the minimum purchase price is in effect on
the Expiration Date. 13 Unlike the Offer, the exchange offer contemplated by the Citizens Republic letter was not subject to Rule 13e-4. We do not view this distinction as significant. www.pillsburylaw.com 601553669-v6-Draft No Action Letter.DOC
Office ofMergers and Acquisitions
Division of Corporation Finance webpage, substantially identical to those for the Offer. 14 Because the Thermo Fisher tender offer was only subject to a minimum, and not a maximum, purchase price, the Company, in accordance with guidance in the Day 20 Split-Off Letters regarding the use of maximum exchange ratio limits, has provided in the Offer that ifthe purchase price for the Subject Securities is the Maximum Purchase Price, there will be a mandatory extension ofthe Offer for an additional two trading days to enable holders to determine whether or not to tender their Subject Securities or to withdraw any previously tendered Subject Securities. We believe that the rationale of the letters to Thermo Fisher Scientific Inc. and Citizens Republic Bancorp, Inc. and the Day 20 Split-Off Letters (collectively, the "Day 20 Letters") applies to the Offer because:
Office of Mergers and Acquisitions
Division of Corporation Finance
October 7,2011
On the basis ofthe foregoing, we respectfully request, on behalf ofthe Company, that the Staff confirm that it will not recommend that the SEC take enforcement action against the Company pursuant to Rules 13e-4(d)(1), 13e-4(f)(1)(ii) and 14e-l(b) under the 1934 Act with the respect to the Company's use ofthe Pricing Mechanism to determine the purchase price to be paid per Subject Security pursuant to the Offer. www.pillsburylaw.com 601553669v6
Office of Mergers and Acquisitions
Division of Corporation Finance
If you have any questions regarding this request or the Offer, please call me at your convenience at (212) 858-1440 or Stanton D. Wong at (415) 983-1790. Very truly yours, Todd W. Eckland cc: Jayne M. Donegan, Esq., Textron Inc. www.pillsburylaw.com 601553669v6
Note from RegAlert. AI assistants can read this document in full, and search 70,000+ more, through the RegAlert MCP connector (https://mcp.regalert.today/mcp). Free with an account. How to connect ChatGPT, Claude or Cursor.
The documents this one cites, and the documents that cite it.
“Accordingly, the Offer is subject to Rule 13e-4 under the Securities Exchange Act of 1934 (the "1934 Act")”
More like this from SEC
SEC published 7 documents in the last 30 days. We email you each new one the day it's published.
Source: Securities and Exchange Commission — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works
In RegAlert: added · updated